Enantioselective Total Synthesis of Some Brevicomins Using Aldolase Antibody 38C2
摘要:
Aldolase antibody 38C2 (Aldrich no. 47,995-0) catalyzes the aldol reaction between hydroxyacetone and aldehyde 7 to give dihydroxyketone 8 alpha in an enantiomeric excess (ee) >99%. This reaction has been performed on a semipreparative scale to give the product in 55% yield (ee=98%). Aldol 8 alpha can be converted to hydroxybrevicomins ent-5 and ent-6 by reduction and acid-catalyzed cyclization. Antibody 38C2 also catalyzes the retro-aldol reaction of racemic syn-8. After 52% conversion, the enantiomeric product (8 beta) is obtained in >99% ee. By using either antibody-catalyzed aldol or retro-aldol reactions, both aldol enantiomers can be prepared with a single antibody catalyst. This methodology has been applied in highly enantioselective total syntheses of ten brevicomins.
Enantioselective Total Synthesis of Some Brevicomins Using Aldolase Antibody 38C2
摘要:
Aldolase antibody 38C2 (Aldrich no. 47,995-0) catalyzes the aldol reaction between hydroxyacetone and aldehyde 7 to give dihydroxyketone 8 alpha in an enantiomeric excess (ee) >99%. This reaction has been performed on a semipreparative scale to give the product in 55% yield (ee=98%). Aldol 8 alpha can be converted to hydroxybrevicomins ent-5 and ent-6 by reduction and acid-catalyzed cyclization. Antibody 38C2 also catalyzes the retro-aldol reaction of racemic syn-8. After 52% conversion, the enantiomeric product (8 beta) is obtained in >99% ee. By using either antibody-catalyzed aldol or retro-aldol reactions, both aldol enantiomers can be prepared with a single antibody catalyst. This methodology has been applied in highly enantioselective total syntheses of ten brevicomins.
Aldolase antibody 38C2 (Aldrich no. 47,995-0) catalyzes the aldol reaction between hydroxyacetone and aldehyde 7 to give dihydroxyketone 8 alpha in an enantiomeric excess (ee) >99%. This reaction has been performed on a semipreparative scale to give the product in 55% yield (ee=98%). Aldol 8 alpha can be converted to hydroxybrevicomins ent-5 and ent-6 by reduction and acid-catalyzed cyclization. Antibody 38C2 also catalyzes the retro-aldol reaction of racemic syn-8. After 52% conversion, the enantiomeric product (8 beta) is obtained in >99% ee. By using either antibody-catalyzed aldol or retro-aldol reactions, both aldol enantiomers can be prepared with a single antibody catalyst. This methodology has been applied in highly enantioselective total syntheses of ten brevicomins.